Real-time analysis

West Pharmaceutical Services, Inc. (WST) Stock Analysis

West Pharmaceutical Services, Inc. · WST

61 /100
Profitability38
Growth100
Financial health19
Valuation62
Momentum71
Risk76
Today's score, computed by the 6-pillar engine · for each pillar, higher = better (risk included) · based on 6/6 pillars

What the analysis says

As of the latest run, West Pharmaceutical Services, Inc. (WST) scores 61/100 overall — a broadly solid profile. Its strongest dimension: growth (100/100); the one that most warrants attention: financial health (19/100).

Three pillars judge the company (profitability, growth, financial health), three judge the stock (valuation, momentum, risk). The score is recomputed every day from Yahoo Finance market data — the one shown above reflects today's state.

Strengths

Growth comes in at 100/100 — sustained revenue growth. The risk pillar comes in at 76/100 — volatility kept in check by market standards. Momentum comes in at 71/100 — a well-oriented price trend.

The breakdown of each pillar — and a plain-English explanation of what it measures — is available in the full analysis, free and updated every day.

Points to watch

Financial health falls to 19/100 — a balance sheet under strain, on debt or liquidity. Profitability falls to 38/100 — thin margins or a disappointing return on capital.

No score replaces your own judgment: Stock Analyzer is a tool for analysis and understanding, not investment advice.

See the full, up-to-date analysis →

Other popular analyses